Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M

Laura Shawver, CEO of Silverback Therapeutics. (Silverback Photo)

Silverback Therapeutics plans to raise up to $151.8 million in its initial public offering, the Seattle-based company said Monday in an updated IPO filing.

The biotech firm will aim to sell 6.95 million shares at $17 to $19 per

…

This post was originally published on this site

contactedorg

Check out https://contacted.org
Banzai raises $15M as investors pour cash into virtual event platforms

Banzai raises $15M as investors pour cash into virtual event platforms

How this Seattle VC missed out on Auth0’s seed round, but persisted and landed a big payoff

How this Seattle VC missed out on Auth0’s seed round, but persisted and landed a big payoff

Tech Moves: Former AT&T Vice Chairman Ralph de la Vega joins Outreach board; Flyhomes adds VPs

Tech Moves: Former AT&T Vice Chairman Ralph de la Vega joins Outreach board; Flyhomes adds VPs

Pioneer Square Labs raises $100M fund for venture arm to back more Pacific Northwest startups

Pioneer Square Labs raises $100M fund for venture arm to back more Pacific Northwest startups

Seattle startup Downstream, which helps brands with their Amazon ads, acquired by Jungle Scout

Seattle startup Downstream, which helps brands with their Amazon ads, acquired by Jungle Scout

Okta to pay $6.5B to acquire Seattle’s Auth0; identity tech startup was valued at $1.9B last year

Okta to pay $6.5B to acquire Seattle’s Auth0; identity tech startup was valued at $1.9B last year

%d bloggers like this: